Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients
- 1 July 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56, S231-S234
- https://doi.org/10.1046/j.1523-1755.1999.07161.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- OXIDATIVE STRESS AND LIPID ABNORMALITIES IN RENAL TRANSPLANT RECIPIENTS WITH OR WITHOUT CHRONIC REJECTION1Transplantation, 1998
- Antioxidative Capacity of Wine on Human LDL Oxidation in Vitro: Effect of Skin Contact in Winemaking of White WineJournal of Agricultural and Food Chemistry, 1997
- HYPERLIPIDEMIA IN SOLID ORGAN TRANSPLANTATIONTransplantation, 1997
- Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDLAtherosclerosis, 1997
- EVALUATION OF FLUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS TAKING CYCLOSPORINE1Transplantation, 1996
- Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coeezyme a reduefase inhibitorThe American Journal of Cardiology, 1995
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991